209 related articles for article (PubMed ID: 26561062)
1. Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants.
Sarrafchi A; Bahmani M; Shirzad H; Rafieian-Kopaei M
Curr Pharm Des; 2016; 22(2):238-46. PubMed ID: 26561062
[TBL] [Abstract][Full Text] [Related]
2. Effect of a phytopharmaceutical medicine, Ginko biloba extract 761, in an animal model of Parkinson's disease: therapeutic perspectives.
Rojas P; Montes P; Rojas C; Serrano-García N; Rojas-Castañeda JC
Nutrition; 2012; 28(11-12):1081-8. PubMed ID: 22817828
[TBL] [Abstract][Full Text] [Related]
3. Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.
Koppula S; Kumar H; More SV; Kim BW; Kim IS; Choi DK
Int J Mol Sci; 2012; 13(8):10608-10629. PubMed ID: 22949883
[TBL] [Abstract][Full Text] [Related]
4. Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts.
Yang F; Wolk A; Håkansson N; Pedersen NL; Wirdefeldt K
Mov Disord; 2017 Nov; 32(11):1631-1636. PubMed ID: 28881039
[TBL] [Abstract][Full Text] [Related]
5. A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
Lee JA; Son HJ; Park KD; Han SH; Shin N; Kim JH; Kim HR; Kim DJ; Hwang O
Neurotox Res; 2015 Nov; 28(4):332-45. PubMed ID: 26233727
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
[TBL] [Abstract][Full Text] [Related]
7. Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.
González-Burgos E; Fernandez-Moriano C; Gómez-Serranillos MP
J Neuroimmune Pharmacol; 2015 Mar; 10(1):14-29. PubMed ID: 25349145
[TBL] [Abstract][Full Text] [Related]
8. Supplementation with Herbal Extracts to Promote Behavioral and Neuroprotective Effects in Experimental Models of Parkinson's Disease: A Systematic Review.
da Costa IM; Cavalcanti JRLP; de Queiroz DB; de Azevedo EP; do Rêgo ACM; Araújo Filho I; Parente P; Botelho MA; Guzen FP
Phytother Res; 2017 Jul; 31(7):959-970. PubMed ID: 28544038
[TBL] [Abstract][Full Text] [Related]
9. Medicinal Plants as Protective Strategies Against Parkinson's Disease.
Mazo NA; Echeverria V; Cabezas R; Avila-Rodriguez M; Tarasov VV; Yarla NS; Aliev G; Barreto GE
Curr Pharm Des; 2017; 23(28):4180-4188. PubMed ID: 28302024
[TBL] [Abstract][Full Text] [Related]
10. Brain aging and Parkinson's disease: New therapeutic approaches using drug delivery systems.
Rodríguez-Nogales C; Garbayo E; Carmona-Abellán MM; Luquin MR; Blanco-Prieto MJ
Maturitas; 2016 Feb; 84():25-31. PubMed ID: 26653838
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
Kumari N; Agrawal S; Kumari R; Sharma D; Luthra PM
Neurosci Lett; 2018 May; 675():74-82. PubMed ID: 29567422
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective action of 4-Hydroxyisophthalic acid against paraquat-induced motor impairment involves amelioration of mitochondrial damage and neurodegeneration in Drosophila.
S N; Shivanandappa T
Neurotoxicology; 2018 May; 66():160-169. PubMed ID: 29653138
[TBL] [Abstract][Full Text] [Related]
13. The Positive Role and Mechanism of Herbal Medicine in Parkinson's Disease.
Yin R; Xue J; Tan Y; Fang C; Hu C; Yang Q; Mei X; Qi D
Oxid Med Cell Longev; 2021; 2021():9923331. PubMed ID: 34567415
[TBL] [Abstract][Full Text] [Related]
14. Can we prevent Parkinson's and Alzheimer's disease?
Kedar NP
J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
[TBL] [Abstract][Full Text] [Related]
15. Curcumin: a potential neuroprotective agent in Parkinson's disease.
Mythri RB; Bharath MM
Curr Pharm Des; 2012; 18(1):91-9. PubMed ID: 22211691
[TBL] [Abstract][Full Text] [Related]
16. Nanodelivery of therapeutic agents in Parkinson's disease.
Lafuente JV; Requejo C; Ugedo L
Prog Brain Res; 2019; 245():263-279. PubMed ID: 30961870
[TBL] [Abstract][Full Text] [Related]
17. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
[TBL] [Abstract][Full Text] [Related]
18. Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease.
Paul R; Phukan BC; Justin Thenmozhi A; Manivasagam T; Bhattacharya P; Borah A
Life Sci; 2018 Jan; 192():238-245. PubMed ID: 29138117
[TBL] [Abstract][Full Text] [Related]
19. Transcribe to survive: transcriptional control of antioxidant defense programs for neuroprotection in Parkinson's disease.
Clark J; Simon DK
Antioxid Redox Signal; 2009 Mar; 11(3):509-28. PubMed ID: 18717631
[TBL] [Abstract][Full Text] [Related]
20. Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism.
Asanuma M; Miyazaki I; Diaz-Corrales FJ; Ogawa N
Acta Med Okayama; 2004 Oct; 58(5):221-33. PubMed ID: 15666991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
